Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancogel for MRSA infected open wounds
NCT00945152Phase 2Unknown
- Start
- Jul 2011
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Vancogel in Staphylococcus aureus infection, skin and soft tissue infection (SSTI). Status: unknown.
02
Drugs
Vancogel
03
Conditions
Staphylococcus aureus infectionskin and soft tissue infection (SSTI)
Beyond the preview
Go deeper on NCT00945152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945152.